Doctor profile · Federal record
Dr. Syed Akhtar, M.D.
Medical Oncology Physician (CMS: Medical Oncology) · Beaumont, TX
- NPI 1124060124
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 37 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
690 N 14Th St, 3Rd Floor
Beaumont, TX 777021449
(409) 899-7180
fax (409) 899-7186 - Mailing address
-
Po Box 911230
Dallas, TX 753911230
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- August 31, 2017
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #L2083
- Medicaid (4)
- TX #146653402 · TX #146653403 · TX #146653404 · TX #146653401
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1124060124. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
111,847
Distinct HCPCS
10
Medicare allowed
$483,744
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 33,150 | 30 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 29,300 | 47 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 17,700 | 30 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 11,779 | 18 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 2,940 | 15 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,505 | 82 | $0 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,900 | 17 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,450 | 37 | $1 | |
J0640 |
Injection, leucovorin calcium, per 50 mg | 993 | 12 | $4 | |
J9190 |
Injection, fluorouracil, 500 mg | 822 | 15 | $2 |
In context: peer comparison
Among 3 peers in Beaumont Medical Oncology Physician, average services per provider: 1,521. This provider delivers 74× the peer median.Open Payments
Industry payments received
All-time total
$1,162
Transactions
42
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $145.38 | |
| Daiichi Sankyo INC. | 2 | $89.41 | |
| Pfizer INC. | 5 | $89.15 | |
| Janssen Biotech, INC. | 5 | $86.91 | |
| Astellas Pharma US INC | 4 | $72.68 | |
| Jazz Pharmaceuticals INC. | 2 | $70.38 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $58.16 | |
| Tempus Ai, INC | 2 | $57.93 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $47.16 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $46.60 | |
| Eisai INC. | 2 | $45.64 | |
| Celgene Corporation | 2 | $40.93 | |
| Merck Sharp & Dohme LLC | 2 | $38.27 | |
| Regeneron Healthcare Solutions, INC. | 2 | $36.61 | |
| Gilead Sciences, INC. | 1 | $25.95 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
865
Patients
197
Total drug cost
$1,029,983
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 115 | 29 | $2,568 |
| Ondansetron Hcl | Generic | 84 | 35 | $945 |
| Potassium Chloride | Generic | 68 | 22 | $1,037 |
| Eliquis (Apixaban) | Brand | 57 | 17 | $52,588 |
| Gabapentin | Generic | 54 | 0 | $656 |
| Prednisone | Generic | 53 | 17 | $278 |
| Dexamethasone | Generic | 52 | 24 | $1,492 |
| Revlimid (Lenalidomide) | Brand | 52 | 0 | $933,767 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 51 | 17 | $1,160 |
| Acyclovir | Generic | 49 | 12 | $754 |
Frequently asked questions
What is Dr. Syed Akhtar's medical specialty?
Dr. Syed Akhtar practices Medical Oncology Physician in Beaumont, TX.
Where does Dr. Syed Akhtar practice?
Dr. Syed Akhtar practices at 690 N 14Th St, Beaumont, TX 777021449. Office phone: 4098997180.
What is Dr. Syed Akhtar's NPI?
Dr. Syed Akhtar's National Provider Identifier (NPI) is 1124060124, issued by NPPES.
Does Dr. Syed Akhtar accept Medicare assignment?
Yes. Dr. Syed Akhtar accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Syed Akhtar commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.